GT Biopharma Inc (GTBP)

[mta65]

Gibba, looks like a catch-up Form D filing for prior sales of stock and debt pursuant to a private placement to 9 accredited investors that started on 8/31/16. It may already be completed. These notices are required by federal law. I read the 10-Qs/10-K which are clear as mud and could not tell if the offering was completed. In order for GT Biopharma to get uplifted to NASDAQ, they are going to undergo a lot of legal scrutiny on all of their prior stock/debt moves. Bottom line, their filings will be much more transparent once they are listed and things will be easier to follow.